Research Article
Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm Infants
Table 4
OR and 95% CI of prognostic factors for severe/moderate BPD based on KL-6/14d.
| Independent variables | Comparison | Crude | Multivariate | OR (95% CI) | OR (95% CI) |
| KL-6/14d (U/ml) | ≥277.5/<277.5 | 8.63 | (3.20–23.25) | 13.59 | (3.19–57.96) | PDA, lung hemorrhage | Yes/No | 8.79 | (1.86–41.57) | 23.34 | (2.14–254.24) | Mechanical ventilation (d) | ≥20/<20 | 14.18 | (5.27–38.19) | 4.45 | (1.23–16.16) | GA (weeks) | ≤26.5/>26.5 | 5.22 | (2.17–12.54) | 4.58 | (1.16–18.06) | Antenatal steroids | Yes/No | 0.34 | (0.12–0.97) | 0.19 | (0.04–0.95) | Sex | Female/Male | 0.81 | (0.36–1.81) | 0.30 | (0.08–1.12) | Weight (g) | ≤855/>855 | 4.71 | (1.98–11.20) | | C-section | Yes/No | 1.19 | (0.49–2.88) | | Complicated pregnancy | Yes/No | 0.76 | (0.19–3.04) | | Apgar score <3 at 1 min | Yes/No | 1.39 | 0.58–3.34 | |
|
|
PDA, persistent ductus arteriosus; GA, gestational age.
|